Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001255294-14-000439
Filing Date
2014-05-15
Accepted
2014-05-15 16:38:15
Documents
10
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 MAINBODY mainbody.htm 10-Q 314787
2 EX31_1 ex31_1.htm EX-31.1 9204
3 EX31_2 ex31_2.htm EX-31.2 9204
4 EX32_1 ex32_1.htm EX-32.1 4097
  Complete submission text file 0001255294-14-000439.txt   1807604

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE vnth-20140331.xml EX-101.INS 121266
6 XBRL SCHEMA FILE vnth-20140331.xsd EX-101.SCH 24202
7 XBRL CALCULATION FILE vnth-20140331_cal.xml EX-101.CAL 29852
8 XBRL DEFINITION FILE vnth-20140331_def.xml EX-101.DEF 55282
9 XBRL LABEL FILE vnth-20140331_lab.xml EX-101.LAB 147409
10 XBRL PRESENTATION FILE vnth-20140331_pre.xml EX-101.PRE 119739
Mailing Address 401 WARREN ST. SUITE 200 REDWOOD CITY CA 94063
Business Address 401 WARREN ST. SUITE 200 REDWOOD CITY CA 94063 310-477-5811
Vantage Health (Filer) CIK: 0001497130 (see all company filings)

EIN.: 980659770 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-55155 | Film No.: 14848005
SIC: 2834 Pharmaceutical Preparations